Kurraba Group

We warmly welcome Pamela Reidenbach as CFO to Kurraba Group. Pam is a CFO with over 15 years of experience in management accounting, specialising in driving financial performance and enhancing margins through strategic planning. Equipped with a bachelor’s degree in Business Administration and CPA certification, together with a recent certification as a Graduate at Australian Institute of Company Directors, Pam has experience across a range of industries, including investment and asset management, medical and healthcare and professional services. She excels in business planning and strategy development, ensuring sustainable growth and profitability for the organisations. At Kurraba, Pam will be leading our financial strategy and operations, driving operational efficiency and supporting our long-term growth objectives. With an impressive track record, together with achieving a certification of we look forward to Pam bringing a wealth of experience and expertise to Kurraba. Outside of work, Pam enjoys ocean swimming, travelling and has a love for the outdoors ! #KurrabaGroup #investment #development #lifesciences #growth

Last week Kurraba Group joined Business Sydney and Paul Nicolaou, together with the The Hon Ed Husic MP, Federal Minister for Industry and Science, addressing how innovation will address the challenges and set Australia up for a positive future. As part of the Albanese Government’s ‘A future Made in Australia’ agenda, Sydney businesses have access to grants of up to $5 million to help start-ups and high growth SMEs to commercialise big ideas. Ed Husic said, “Turning Aussie know how into thriving businesses and secure, well-paid jobs is at the heart of a Future Made in Australia. So far more than 340 businesses have already accessed the advice side of the IGP, showing a healthy pipeline of new know-how that’s ready for commercialisation.” The Life Sciences industry is thriving here in Australia and this IGP initiative will support our tenants, and future tenants at both 1 Central Avenue Eveleigh and our 100 Botany Road Waterloo project in planning, bringing their ideas to life ! Thank you Richard Lenarduzzi for the invitation. Lachlan Clancy Nick Smith #Kurraba #Lifesciences #Waterloo #Investmentmanagers #Developmentmanagers

Kurraba Group is excited to announce the launch of Australia’s first commercial life sciences Campus, a $490-million development in the heart of Sydney’s emerging health and innovation precinct. Located at 100 Botany Road, Waterloo, just 2kms from the CBD, the strategically-located 26,642sqm development site will house hi-tech laboratories, knowledge workspaces, and the necessary infrastructure and facilities for professionals working in Australia’s rapidly-evolving life sciences sector, creating over 1,200 jobs. The Campus will drive investment, productivity and high-growth across advanced medical and health sciences industries, creating a robust platform for local research and development (R&D) to be commercialised in Australia, strengthening sovereign capabilities and ensuring that valuable IP is not ‘lost’ off-shore. Nick Smith, CEO Kurraba said, “The development, opposite the new Waterloo Metro Station, would be a real catalyst for the urban renewal and transformation of the vibrant Botany Road corridor. The team at Kurraba and our investment partners are delighted to be launching this exciting new development, which will be Australia’s first-ever commercial life sciences precinct. The project recently achieved its first milestone with renowned global architect Gensler, winning the NSW Government Architects Design Excellence Competition for the development. Gensler’s design for the state-of-the-art facility is tailored to the unique needs of the life sciences sector, with a focus on sustainability and strong ESG principles. Kurraba is expected to lodge a SSDA for the project next month with construction due to commence in early 2025. See the full article on the Kurraba website, https://lnkd.in/gaZwRzzw Or read the article in The Australian today, https://lnkd.in/gtJKwsaN Nick Smith Richard Campbell Steve Ryan Lachlan ClancyJohannes van Reesema Kate Evans Pamela Reidenbach  Ashleigh Henare #kurrabagroup #lifesciences #waterloo #centreforexcellence #developmentexperts 

It is great to see Ed Husic MP, Minister for Industry and Science supporting Australian researchers, biomedical and life sciences. Kurraba Group is soon to share some very exciting news to further support the Australian life sciences industry, supporting R&D and creating new manufacturing opportunities and local jobs. Watch this space ... Nick Smith Richard Campbell Steve Ryan Johannes van Reesema Lachlan Clancy Kate Evans

This World Environment Day, Kurraba Group are taking the chance to highlight I2SL: International Institute for Sustainable Laboratories and its impact on the Life Sciences industry.    Committed to improving sustainability performance in laboratories and controlled environments, the I2SL aims to plan, deliver and operate high energy/utility consuming facilities in a more sustainable way, so that Life Sciences professionals working in our facilities can focus on research and innovation for the sector.    Together, change for good is easy. ♻️   #LifeSciences #I2SL #sustainablelabs #KurrabaGroup

This past week, we celebrated Clinical Trials Day.   A day to be reminded of the crucial role of clinical trials in advancing medical research, the dedication of our researchers, and invaluable contribution of patient volunteers.    Clinical research is an important and necessary function of the Life Sciences sector, serving as the conduit through which transformative medical breakthroughs are realised, positively impacting lives for the better.    At Kurraba Group, we understand the significance of clinical trials and are committed to creating next generation ecosystems that support research and innovation.   To find out more and learn how you can join us in supporting this cause, visit https://lnkd.in/dntwPw9B   #clinicaltrialsday #medicalresearch #lifesciences #healthcare #innovation #kurrabagroup

The team are very pleased to announce Kurraba Group managed the latest acquisition, on behalf of a private investor, at 1 Central Avenue, South Eveleigh, NSW for $103M. The asset, known as the Biomedical Building, is based in Sydney's CBD-fringe technology hub South Eveleigh and was purchased from Centuria Capital Group. The acquisition further solidifies Kurraba’s Life Science strategy that is focused on developing unique assets in the most sought-after locations that benefit from precinct renewal and government infrastructure, proximity to leading universities and institutes, and access to Australia’s world-class talent pool. Kurraba Group CEO Nick Smith said, “The BioMed Building at 1 Central Avenue, underpinned by the University of Sydney’s Life Science departments and surrounded by complementary occupiers, such as Cicada Innovations, is a key pillar in our cluster model aspirations for the Sydney Fringe commercial market. “We are thrilled to see the portfolio take shape and excited to build upon further pipeline opportunities with our capital partners, creating exciting new environments for the next generation of R&D and innovation.” For more information read more on the Kurraba website, https://lnkd.in/gAWWiyNb Please see the link to The Australian Financial Review article, https://lnkd.in/grGpUP7n Nick Smith Richard Campbell Steve Ryan Johannes van Reesema Lachlan Clancy Kate Evans #KurrabaGroup #acquistion #lifescience #sydney

Introducing the Kurraba team.    Made up of specialised experts with a proven track record in real estate investment, development and asset management, with a depth of knowledge and expertise in institutional property and complex development.   At Kurraba, we believe in responsible urban transformation that creates resilient, sustainable outcomes for industry and community, whether it’s a revitalisation of an existing asset or development of a new facility.   We understand the evolving needs of the life sciences sector in which we specialise. We bring fresh thinking to new opportunities, invest in cutting edge R&D and build for the future.    Learn more about our team on the website: https://lnkd.in/gbTyFfnZ #KurrabaGroup #RealEstateInnovation #CommunityImpact #SustainableDevelopment #LifeSciences #InvestingInEcosystems #EmpoweringCommunities Nick Smith Richard Campbell Steve Ryan Johannes van Reesema Lachlan Clancy Kate Evans Ashleigh Henare

Australia has a strong culture of innovation and investment in research that has made our nation an important incubator of advancements in cutting-edge technology within the Life Sciences sector. As a country, we consistently rank highly among Nature Index’s top 10 contributors. The Life Sciences sector encompasses pharmaceuticals, biotechnology, medical devices, biomedical technologies, agrisciences, agtech, marine science, nutraceuticals, cosmeceuticals, food processing, and more. It’s this diversity that fuels collaboration and innovation, driving breakthroughs that enhance our lives. Over the next 10 years the co-ordinated effort across the life sciences research, innovation and biotechnology sectors is expected to significantly contribute to our society and economy. As a nation, we produce world leading intellectual property within the sector, however none of the downstream economics and job multipliers are captured and as a result real estate development is not keeping up with the pace. Kurraba Group was founded to solve this problem and bridge the gap. We bring together smart investment with innovative vision to create environments that nurture the groundbreaking discoveries borne within the momentum of this fascinating and inspiring industry. Join us as we work together on what’s next. 🧬🌱 #KurrabaGroup #RealEstateInnovation #CommunityImpact #SustainableDevelopment #LifeSciences #InvestingInEcosystems #EmpoweringCommunities #Waterloo #NatureIndex

Kurraba Group‘s innovative developments cater to the specific needs of the life sciences industry, to help investors access the growth potential and above all, to help communities harness the latest innovations to enable a better quality of life.   Given the growth of the life sciences sector, specialised real estate and building management are imperative to cultivate environments that inspire fresh thinking, attract top-tier talent and drive innovation forward.   We create the right environments for today, for the big breakthroughs of tomorrow.    #KurrabaGroup #RealEstateInnovation #CommunityImpact #SustainableDevelopment #LifeSciences #InvestingInEcosystems #EmpoweringCommunities #Waterloo